The Impact of Unrestricted Transportation Passes on HIV Treatment and Service Outcomes: Results from a Randomized Controlled Trial among Unstably Housed People Living with HIV

Abstract Background Unstably housed people living with HIV (PLWH) face barriers to achieving and maintaining viral suppression. Transportation instability limits access to medical care and supportive services. Prior research has proposed transportation passes as a potential intervention. However, the effectiveness of this approach has not been evaluated. Methods This prospective randomized controlled trial recruited 146 unstably housed PLWH from a community-based organization serving PLWH in a Midwest city. Participants randomized to the intervention group received an unrestricted public transit pass for 6 months, while the control group retained their current benefits. Surveys administered at baseline and six-month follow-up assessed housing and transportation instability and quality of life. Viral load lab results and social service utilization were extracted from administrative databases. Results Logistic regression found no evidence of an effect of the intervention on the study’s primary outcome of viral suppression (OR .97; 95% CI: 0.47–2.01; p=.942) across multiple missing-data approaches. Models accounted for baseline indicators. Most secondary outcomes, including meals served, stable housing, employment, and quality-of-life scores, also showed no evidence of an effect. However, in a negative binomial model, the intervention affected the frequency of engagement with case management services, with the intervention arm having an estimated rate of recorded follow-up case management contacts 2.24 times that of the control arm (95% CI, 1.03 to 4.88; p = 0.042). Furthermore, stable housing and employment at follow-up clustered strongly in the intervention group (ratio of ORs: 48.9; p = .004). Conclusion Many supportive services are geared toward stabilizing PLWH experiencing homelessness to help them achieve and maintain viral suppression. However, transportation access is an oft-overlooked structural determinant of health. This study finds no evidence of a direct clinical effect of transportation passes during the follow-up period. Increased engagement with case management, though, is valuable and is associated with long-term health and stabilization benefits. The increased service engagement might warrant the relatively low cost of $16 per participant per month. The increased service engagement and exploratory stabilization findings suggest mechanisms by which transportation access might have clinical benefits at longer follow-up periods. Trial Registration The trial was prospectively registered with clinicaltrials.gov NCT06483152 on July 3, 2024.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11540634/v1
Primary Topic
Homelessness and Social Issues
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The Impact of Unrestricted Transportation Passes on HIV Treatment and Service Outcomes: Results from a Randomized Controlled Trial among Unstably Housed People Living with HIV

Jay Orne, Zoe Geisen, Nancy Benedict, Grant Shipp
1 links
Research Square
Homelessness and Social Issues
preprint

The Impact of Unrestricted Transportation Passes on HIV Treatment and Service Outcomes: Results from a Randomized Controlled Trial among Unstably Housed People Living with HIV

Jay Orne, Zoe Geisen, Nancy Benedict, Grant Shipp
preprint en

Abstract

Abstract Background Unstably housed people living with HIV (PLWH) face barriers to achieving and maintaining viral suppression. Transportation instability limits access to medical care and supportive services. Prior research has proposed transportation passes as a potential intervention. However, the effectiveness of this approach has not been evaluated. Methods This prospective randomized controlled trial recruited 146 unstably housed PLWH from a community-based organization serving PLWH in a Midwest city. Participants randomized to the intervention group received an unrestricted public transit pass for 6 months, while the control group retained their current benefits. Surveys administered at baseline and six-month follow-up assessed housing and transportation instability and quality of life. Viral load lab results and social service utilization were extracted from administrative databases. Results Logistic regression found no evidence of an effect of the intervention on the study’s primary outcome of viral suppression (OR .97; 95% CI: 0.47–2.01; p=.942) across multiple missing-data approaches. Models accounted for baseline indicators. Most secondary outcomes, including meals served, stable housing, employment, and quality-of-life scores, also showed no evidence of an effect. However, in a negative binomial model, the intervention affected the frequency of engagement with case management services, with the intervention arm having an estimated rate of recorded follow-up case management contacts 2.24 times that of the control arm (95% CI, 1.03 to 4.88; p = 0.042). Furthermore, stable housing and employment at follow-up clustered strongly in the intervention group (ratio of ORs: 48.9; p = .004). Conclusion Many supportive services are geared toward stabilizing PLWH experiencing homelessness to help them achieve and maintain viral suppression. However, transportation access is an oft-overlooked structural determinant of health. This study finds no evidence of a direct clinical effect of transportation passes during the follow-up period. Increased engagement with case management, though, is valuable and is associated with long-term health and stabilization benefits. The increased service engagement might warrant the relatively low cost of $16 per participant per month. The increased service engagement and exploratory stabilization findings suggest mechanisms by which transportation access might have clinical benefits at longer follow-up periods. Trial Registration The trial was prospectively registered with clinicaltrials.gov NCT06483152 on July 3, 2024.

Research Square
University of Minnesota (US)
Gilead Sciences
Good health and well-being, Reduced inequalities
Homelessness and Social Issues
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon